Fuse Medical, Inc. Overview
Pro stress-test →Fuse Medical, Inc. (OTCPINK: FZMD) is an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace. The company provides a comprehensive portfolio of products in the orthopedic total joints, sports medicine, trauma, foot and ankle space, as well as, degenerative and deformity spine, osteobiologics, wound care, and regenerative products.
Strategic Profile
Pro stress-test →Fuse demonstrated strong financial performance in the second quarter of 2023, highlighted by a 7% increase in revenue, a 31% increase in gross profit, and a $648,408 increase in EBITDA over the prior-year period. The company pursues growth through expanding its portfolio of proprietary branded and manufactured products, targeting hospitals, medical facilities, and sub-distributors across the US market.
Competitive Landscape
Pro stress-test →Fuse competes in the fragmented orthopedic devices market against larger, well-capitalized public medical device manufacturers including Zimmer Biomet (orthopedic implants and biologics), Stryker Corporation (trauma, spine, and joint reconstruction), Medtronic (spine and biologics), and regional distributors. Fuse's differentiation relies on proprietary product innovation, direct distributor relationships, and focus on niche segments (compression stapling, dermal matrices). Its smaller scale and OTC status place it in a competitive disadvantage relative to peers with established hospital relationships and sales infrastructure.
Industry Context
Fuse Medical, Inc. operates in Orthopedic medical devices and bone biologics.
Key facts
Headquarters: Richardson, Texas, US · Employees: 11-50 · Revenue: $20.4M (FY 2021) · Market cap: N/A